APA (7th ed.) Citation

Jie, Q., Li, Y., Jing, L., Chen, J., & Li, Y. (2024, September). Adverse event profile differences between pralsetinib and selpercatinib: A real-world study based on the FDA adverse events reporting system. Frontiers in Pharmacology.

Chicago Style (17th ed.) Citation

Jie, Qiong, Yuanyuan Li, Li Jing, Jinjin Chen, and Yang Li. "Adverse Event Profile Differences Between Pralsetinib and Selpercatinib: A Real-world Study Based on the FDA Adverse Events Reporting System." Frontiers in Pharmacology Sep. 2024.

MLA (9th ed.) Citation

Jie, Qiong, et al. "Adverse Event Profile Differences Between Pralsetinib and Selpercatinib: A Real-world Study Based on the FDA Adverse Events Reporting System." Frontiers in Pharmacology, Sep. 2024.